Oruka Therapeutics announced that it will receive $275 million in a round of funding on April 3, 2024. The transaction included participation from syndicate of healthcare investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 USD | -3.63% | +0.58% | +104.12% |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+104.12% | 51.91M | |
-2.47% | 103B | |
+1.91% | 95.28B | |
+1.46% | 22.15B | |
-15.70% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.68% | 16.05B | |
+5.34% | 13.68B | |
+34.93% | 12.17B |
- Stock Market
- Equities
- ABIO Stock
- News ARCA biopharma, Inc.
- Oruka Therapeutics announced that it expects to receive $275 million in funding